Philip D Loetscher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Philip D Loetscher has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Astrid Fahlenkamp
Department of Anesthesiology, University Hospital of the RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany
1 shared publication - Jan Rossaint
Department of Anesthesiology, University Hospital of the RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany
1 shared publication - Joachim Weis
Institute of Neuropathology, Uniklinik RWTH Aachen, 52074 Aachen, Germany
1 shared publication - Mark Coburn
Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany
1 shared publication - Michael Fries
Uniklinik RWTH Aachen
1 shared publication - Oliver Grottke
Department of Anesthesiology, RWTH Aachen University Hospital, Aachen, Germany
1 shared publication
Latest Publications
- Open Access
- 17 December 2009
- Published by Springer Nature in Critical Care
- Vol. 13 (6) , R206
Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury
Introduction: Recently, it has been shown in several experimental settings that the noble gases xenon and helium have neuroprotective properties. In this study we tested the hypothesis that the noble gas argon has a neuroprotective potential as well. Since traumatic brain injury and stroke are widespread and generate an enormous economic and social burden, we investigated the possible neuroprotective effect in in vitro models of traumatic brain injury and cerebral ischemia. Methods: Organotypic hippocampal slice cultures from mice pups were subjected to either oxygen-glucose deprivation or to a focal mechanical trauma and subsequently treated with three different concentrations (25, 50 and 74%) of argon immediately after trauma or with a two-or-three-hour delay. After 72 hours of incubation tissue injury assessment was performed using propidium iodide, a staining agent that becomes fluorescent when it diffuses into damaged cells via disintegrated cell membranes. Results: We could show argon's neuroprotective effects at different concentrations when applied directly after oxygen-glucose deprivation or trauma. Even three hours after application, argon was still neuroprotective. Conclusions: Argon showed a neuroprotective effect in both in vitro models of oxygen-glucose deprivation and traumatic brain injury. Our promising results justify further in vivo animal research.
- 17 December 2009
- Published by Springer Nature in Critical Care
- Vol. 13 (6) , R206
Open AccessArgon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury
Introduction: Recently, it has been shown in several experimental settings that the noble gases xenon and helium have neuroprotective properties. In this study we tested the hypothesis that the noble gas argon has a neuroprotective potential as well. Since traumatic brain injury and stroke are widespread and generate an enormous economic and social burden, we investigated the possible neuroprotective effect in in vitro models of traumatic brain injury and cerebral ischemia. Methods: Organotypic hippocampal slice cultures from mice pups were subjected to either oxygen-glucose deprivation or to a focal mechanical trauma and subsequently treated with three different concentrations (25, 50 and 74%) of argon immediately after trauma or with a two-or-three-hour delay. After 72 hours of incubation tissue injury assessment was performed using propidium iodide, a staining agent that becomes fluorescent when it diffuses into damaged cells via disintegrated cell membranes. Results: We could show argon's neuroprotective effects at different concentrations when applied directly after oxygen-glucose deprivation or trauma. Even three hours after application, argon was still neuroprotective. Conclusions: Argon showed a neuroprotective effect in both in vitro models of oxygen-glucose deprivation and traumatic brain injury. Our promising results justify further in vivo animal research.